Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Nat Nanotech
Supplementary material The Supplementary Material for this article can be found online at: References 1 GuYLiHBaoXZhangQLiuLMengGet al
View full details Subscription Price: (10% Off)
Iraji F, Nasimi M, Asilian A, Faghihi G, Mozafarpoor S, Hafezi H
The co-treatment of the cells with 3-PLG-ibu (100 g/ml) or 0.9 M ibuprofen (the estimated drug content of 3-PLG-ibu nanocarrier) did not change the toxicity of CK treatment after 24 h
Involvement of IGF-1/IGFBP-3 signaling on the conspicuousness of facial pores [PMID: 20567839] Laboratory literature summary: Involvement of IGF-1/IGFBP-3 signaling on the conspicuousness of facial pores
US$ 26.57
US$ 20.72
US$ 21.89
US$ 28.73
